Ann Greer
Baylor College of Medicine(US)
Publications by Year
Research Areas
Growth Hormone and Insulin-like Growth Factors, Metabolism, Diabetes, and Cancer, Cancer, Hypoxia, and Metabolism, PI3K/AKT/mTOR signaling in cancer, Plant tissue culture and regeneration
Most-Cited Works
- → BMS-754807, a small molecule inhibitor of insulin-like growth factor-1R/IR(2009)278 cited
- → Tumor Development by Transgenic Expression of a Constitutively Active Insulin-Like Growth Factor I Receptor(2005)203 cited
- → The Mechanisms of Differential Sensitivity to an Insulin-like Growth Factor-1 Receptor Inhibitor (BMS-536924) and Rationale for Combining with EGFR/HER2 Inhibitors(2008)163 cited
- → Discovery of a 1H-Benzoimidazol-2-yl)-1H-pyridin-2-one (BMS-536924) Inhibitor of Insulin-like Growth Factor I Receptor Kinase with in Vivo Antitumor Activity(2005)134 cited
- → Differential Mechanisms of Acquired Resistance to Insulin-like Growth Factor-I Receptor Antibody Therapy or to a Small-Molecule Inhibitor, BMS-754807, in a Human Rhabdomyosarcoma Model(2010)115 cited
- → Discovery of a 2,4-Disubstituted Pyrrolo[1,2-f][1,2,4]triazine Inhibitor (BMS-754807) of Insulin-like Growth Factor Receptor (IGF-1R) Kinase in Clinical Development(2009)94 cited
- → Isolation of an osmotic stress- and abscisic acid-induced gene encoding an acidic endochitinase from Lycopersicon chilense(1994)73 cited
- → Dual IGF-1R/InsR Inhibitor BMS-754807 Synergizes with Hormonal Agents in Treatment of Estrogen-Dependent Breast Cancer(2011)72 cited
- → Imidazole moiety replacements in the 3-(1H-benzo[d]imidazol-2-yl)pyridin-2(1H)-one inhibitors of insulin-like growth factor receptor-1 (IGF-1R) to improve cytochrome P450 profile(2007)46 cited
- → Discovery and initial SAR of 3-(1H-benzo[d]imidazol-2-yl)pyridin-2(1H)-ones as inhibitors of insulin-like growth factor 1-receptor (IGF-1R)(2007)40 cited